Your browser doesn't support javascript.
loading
Becker muscular dystrophy severity is linked to the structure of dystrophin.
Nicolas, Aurélie; Raguénès-Nicol, Céline; Ben Yaou, Rabah; Ameziane-Le Hir, Sarah; Chéron, Angélique; Vié, Véronique; Claustres, Mireille; Leturcq, France; Delalande, Olivier; Hubert, Jean-François; Tuffery-Giraud, Sylvie; Giudice, Emmanuel; Le Rumeur, Elisabeth.
Afiliação
  • Nicolas A; Université de Rennes 1, Avenue du Professeur Léon Bernard, 35043 Rennes, France, CNRS UMR 6290, Institut de Génétique et Développement de Rennes, 35043 Rennes, France.
  • Raguénès-Nicol C; Université de Rennes 1, Avenue du Professeur Léon Bernard, 35043 Rennes, France, CNRS UMR 6290, Institut de Génétique et Développement de Rennes, 35043 Rennes, France.
  • Ben Yaou R; Inserm, U974, Université Pierre et Marie Curie-Paris 6, UM 76, CNRS, UMR 7215, Institut de Myologie, Paris 75013, France, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre de Référence de Pathologie Neuromusculaire Paris-Est, Paris 75013 France.
  • Ameziane-Le Hir S; Université de Rennes 1, Avenue du Professeur Léon Bernard, 35043 Rennes, France, CNRS UMR 6290, Institut de Génétique et Développement de Rennes, 35043 Rennes, France.
  • Chéron A; Université de Rennes 1, Avenue du Professeur Léon Bernard, 35043 Rennes, France, CNRS UMR 6290, Institut de Génétique et Développement de Rennes, 35043 Rennes, France.
  • Vié V; Université de Rennes 1, Avenue du Professeur Léon Bernard, 35043 Rennes, France, CNRS UMR 6251, Institut de Physique de Rennes, Rennes, France.
  • Claustres M; CHU Montpellier, Hôpital Arnaud de Villeneuve, Laboratoire de Génétique Moléculaire, 34000 Montpellier, France, Faculté de Médecine, Université Montpellier 1, 34000 Montpellier, France, Inserm U827, 34000 Montpellier, France and.
  • Leturcq F; Inserm, U974, Université Pierre et Marie Curie-Paris 6, UM 76, CNRS, UMR 7215, Institut de Myologie, Paris 75013, France, AP-HP, Laboratoire de Biochimie et Génétique Moléculaire, Groupe Hospitalier Cochin-Broca-Hotel-Dieu, Paris, France.
  • Delalande O; Université de Rennes 1, Avenue du Professeur Léon Bernard, 35043 Rennes, France, CNRS UMR 6290, Institut de Génétique et Développement de Rennes, 35043 Rennes, France.
  • Hubert JF; Université de Rennes 1, Avenue du Professeur Léon Bernard, 35043 Rennes, France, CNRS UMR 6290, Institut de Génétique et Développement de Rennes, 35043 Rennes, France.
  • Tuffery-Giraud S; Faculté de Médecine, Université Montpellier 1, 34000 Montpellier, France, Inserm U827, 34000 Montpellier, France and.
  • Giudice E; Université de Rennes 1, Avenue du Professeur Léon Bernard, 35043 Rennes, France, CNRS UMR 6290, Institut de Génétique et Développement de Rennes, 35043 Rennes, France.
  • Le Rumeur E; Université de Rennes 1, Avenue du Professeur Léon Bernard, 35043 Rennes, France, CNRS UMR 6290, Institut de Génétique et Développement de Rennes, 35043 Rennes, France, elisabeth.lerumeur@univ-rennes1.fr.
Hum Mol Genet ; 24(5): 1267-79, 2015 Mar 01.
Article em En | MEDLINE | ID: mdl-25348330
ABSTRACT
In-frame exon deletions of the Duchenne muscular dystrophy (DMD) gene produce internally truncated proteins that typically lead to Becker muscular dystrophy (BMD), a milder allelic disorder of DMD. We hypothesized that differences in the structure of mutant dystrophin may be responsible for the clinical heterogeneity observed in Becker patients and we studied four prevalent in-frame exon deletions, i.e. Δ45-47, Δ45-48, Δ45-49 and Δ45-51. Molecular homology modelling revealed that the proteins corresponding to deletions Δ45-48 and Δ45-51 displayed a similar structure (hybrid repeat) than the wild-type dystrophin, whereas deletions Δ45-47 and Δ45-49 lead to proteins with an unrelated structure (fractional repeat). All four proteins in vitro expressed in a fragment encoding repeats 16-21 were folded in α-helices and remained highly stable. Refolding dynamics were slowed and molecular surface hydrophobicity were higher in fractional repeat containing Δ45-47 and Δ45-49 deletions compared with hybrid repeat containing Δ45-48 and Δ45-51 deletions. By retrospectively collecting data for a series of French BMD patients, we showed that the age of dilated cardiomyopathy (DCM) onset was delayed by 11 and 14 years in Δ45-48 and Δ45-49 compared with Δ45-47 patients, respectively. A clear trend toward earlier wheelchair dependency (minimum of 11 years) was also observed in Δ45-47 and Δ45-49 patients compared with Δ45-48 patients. Muscle dystrophin levels were moderately reduced in most patients without clear correlation with the deletion type. Disease progression in BMD patients appears to be dependent on the deletion itself and associated with a specific structure of dystrophin at the deletion site.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Distrofina / Distrofia Muscular de Duchenne Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Distrofina / Distrofia Muscular de Duchenne Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article